Medicare Enrolled
Dr. Rao Pasupuleti, M.D.
Neurology · Hamilton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pasupuleti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pasupuleti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pasupuleti
Dr. Rao Pasupuleti is a neurology specialist in Hamilton, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pasupuleti performed 989 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pasupuleti received a total of $11,310 from 71 pharmaceutical and/or device companies across 778 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pasupuleti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 39% volume in NJ
$11,310 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗989
Medicare services
Top 39% in NJ for neurology
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
437 | $63 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
233 | $66 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
65 | $145 | $350 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
63 | $83 | $225 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $89 | $228 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
55 | $240 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $123 | $271 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
22 | $114 | $375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $108 | $250 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
13 | $162 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,310
Total received (2018-2024)
Avg $1,616/year across 7 years
Top 23% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
778
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,486
2023
$1,890
2022
$1,703
2021
$1,543
2020
$1,159
2019
$1,913
2018
$1,616
Payments by company (2024)
Tris Pharma Inc
$258
EMD Serono, Inc.
$225
ABBVIE INC.
$160
Novartis Pharmaceuticals Corporation
$156
Corium, LLC
$136
Supernus Pharmaceuticals, Inc.
$130
SK Life Science, Inc.
$73
Biogen, Inc.
$47
Sumitomo Pharma America, Inc.
$46
Neurelis, Inc.
$44
Abbott Laboratories
$42
Lilly USA, LLC
$35
Eisai Inc.
$21
UCB, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$18
ARGENX US, INC.
$18
Noven Therapeutics, LLC
$16
Medtronic, Inc.
$14
Grifols USA, LLC
$13
IRONSHORE PHARMACEUTICALS INC.
$13
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,142
Biogen, Inc.
$1,022
EMD Serono, Inc.
$643
Corium, LLC
$616
UCB, Inc.
$602
ABBVIE INC.
$572
Novartis Pharmaceuticals Corporation
$499
Tris Pharma Inc
$497
Sunovion Pharmaceuticals Inc.
$377
Teva Pharmaceuticals USA, Inc.
$347
Neos Therapeutics, LP
$337
Takeda Pharmaceuticals U.S.A., Inc.
$329
Eisai Inc.
$263
Lilly USA, LLC
$193
SK Life Science, Inc.
$181
Celgene Corporation
$173
Neurelis, Inc.
$169
Ironshore Pharmaceuticals Inc.
$169
Sumitomo Pharma America, Inc.
$154
Biohaven Pharmaceuticals, Inc.
$152
Alexion Pharmaceuticals, Inc.
$152
AQUESTIVE THERAPEUTICS, INC.
$145
Aprecia Pharmaceuticals, LLC
$141
Amgen Inc.
$139
ARBOR PHARMACEUTICALS, INC.
$132
Rhodes Pharmaceuticals L.P.
$129
Shire North American Group Inc
$125
AbbVie Inc.
$119
Avanir Pharmaceuticals, Inc.
$119
Greenwich Biosciences, Inc.
$108
EISAI INC.
$94
JAZZ PHARMACEUTICALS INC.
$90
IMPEL PHARMACEUTICALS INC.
$84
LivaNova USA, Inc.
$84
Biohaven Pharmaceutical Holding Company Ltd.
$77
Abbott Laboratories
$72
Promius Pharma LLC
$72
Jazz Pharmaceuticals Inc.
$69
Neurocrine Biosciences, Inc.
$59
Mallinckrodt Hospital Products Inc.
$55
Mallinckrodt Enterprises LLC
$54
GENZYME CORPORATION
$52
Amneal Pharmaceuticals LLC
$51
Boston Scientific Corporation
$50
Genentech USA, Inc.
$40
Acorda Therapeutics, Inc
$35
UPSHER-SMITH LABORATORIES LLC
$32
BOSTON SCIENTIFIC CORPORATION
$31
Strongbridge US INC.
$30
Janssen Pharmaceuticals, Inc
$29
Horizon Therapeutics plc
$29
Adamas Pharmaceuticals, Inc.
$29
Vertical Pharmaceuticals, LLC
$27
Bayer HealthCare Pharmaceuticals Inc.
$25
Grifols USA, LLC
$25
Allergan Inc.
$25
Kyowa Kirin, Inc.
$25
BioMarin Pharmaceutical Inc.
$22
PFIZER INC.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
ARGENX US, INC.
$18
Bausch Health US, LLC
$17
Noven Therapeutics, LLC
$16
Adlon Therapeutics L.P.
$15
Impax Laboratories, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Medtronic, Inc.
$14
IRONSHORE PHARMACEUTICALS INC.
$13
Upsher-Smith Laboratories LLC
$13
Amarin Pharma Inc.
$12
Medtronic Vascular, Inc.
$11
Top 3 companies account for 24.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADHANSIA XR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · AZSTARYS · Adlarity · Aduhelm · Adzenys XR-ODT · Aimovig · Aptensio XR · Austedo XR · Azstarys · BOTOX · Betaseron · Brineura · Briviact · COPAXONE · Cotempla XR-ODT · DIVIGEL · Dyanavel XR · EMGALITY · EPIDIOLEX · Epidiolex · Evekeo · Evekeo ODT · Fycompa · GENERAL PAIN MANAGEMENT · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KEVEYIS · KYNMOBI · Leqembi · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · MIGRANAL · MYDAYIS · Mavenclad · NOURIANZ · NUEDEXTA · NURTEC ODT · Neuromodulation Dspsbls and Accs · OCREVUS · ONZETRA Xsail · OXTELLAR XR · Onyda XR · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · Quillivant · RYTARY · Rebif · Reveal LINQ · SEGLENTIS · SOLIRIS · SUNOSI · SYMPAZAN · Soliris · Spritam · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VUMERITY · VYVANSE · VYVGART HYTRULO · Vascepa · Vimpat · Vyvanse · Xelstrym · Xembify · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
140
County median income
$96,333
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT HAMILTON
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pasupuleti is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pasupuleti experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pasupuleti performed 437 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pasupuleti receive payments from pharmaceutical companies?
Yes. Dr. Pasupuleti received a total of $11,310 from 71 companies across 778 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pasupuleti's costs compare to other neurologists in Hamilton?
Dr. Pasupuleti's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pasupuleti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Hamilton
Browse neurologists in Hamilton ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology